According to the Washington Post, what started as an antitrust lawsuit brought by states over just two drugs in 2016 has exploded into an investigation of alleged price-fixing involving at least 16 companies and 300 drugs.
Questions:
1. What was the “shorthand” between executives used for? Give an example.
2. According to the article, who are the victims of these price-fixing schemes?
3. Who are some of the companies that banded together for price-fixing and what are some of the extraordinary percentage markups charged?
4. What did you find the most interesting about this article?
Source:
Rowland, C. (2018). Investigation of generic ‘cartel’ expands to 300 drugs. Washington Post, Dec. 9 (Retrievable online at https://www.washingtonpost.com/business/economy/investigation-of-generic-cartel-expands-to-300-drugs/2018/12/09/fb900e80-f708-11e8-863c-9e2f864d47e7_story.html)